A prospective real-world analysis of intravenous eptinezumab in migraine management: the first UK experience
Abstract Background Clinical trials have shown the safety and statistical superiority of intravenous eptinezumab to placebo in migraine prevention in adults. However, data in real-world settings is sparse. Methods This is a prospective open-label single centre real-world analysis aiming to establish...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2025-10-01
|
| シリーズ: | The Journal of Headache and Pain |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s10194-025-02180-3 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|